LC16m8: long term immunity is the way to eradicate monkey pox
Another addition to the trend of infectious epidemic diseases instituted by Corona Virus is the monkey pox virus, a concept endemic to the nations of Africa but now globalized in the 2022-2023 epidemic.
Klingelhöfer D, Braun M, Groneberg DA, Brüggmann D. Global mpox research in the light of the current outbreak: demands, drivers, and obstacles. Emerg Microbes Infect. 2023;12(1):2210696.
2022-2023 mpox outbreak. Wikipedia. Available at: https://en.wikipedia.org/wiki/2022%E2%80%932023_mpox_outbreak. Accessed on 05 June, 2023.
Kaler J. Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation. Cureus. 2022;14(7):e26531.
Potential Risk for New Mpox Cases. CDC Health Alert Network. 2023. Available at: https://emergency.cdc.gov/han/2023/han00490.asp. Accessed on 05 June, 2023.
Eto A, Saito T, Yokote H, Kurane I, Kanatani Y. Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8. Vaccine. 2015;33(45):6106-11.
Saito T, Fujii T, Kanatani Y, Saijo M, Morikawa S, Yokote H et al. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. JAMA. 2009;301(10):1025-33.
Kennedy JS. Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults. J Infect Dis. 2011;204(9):1395-402.
Kenner J. LC16m8: An attenuated smallpox vaccine. Vaccine. 2006;24(17):3701.